Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Nicoletti

Showing results (11-20 of 577) with videos related to

Pageof 58
Sort By:
Current Opinion in Pharmacology|May 13, 2018
Editorial overview: Neurosciences: Metabotropic glutamate receptors: still promising drug targets for CNS disordersFerdinando Nicoletti, Giuseppe Battaglia, Valria Bruno
Neuropharmacology|July 22, 2008
2008 Eruptions in metabotropic glutamate receptorsFerdinando Nicoletti, Graham Collingridge, Darryle Schoepp
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 21, 2010
The advent of monoclonal antibodies in the treatment of chronic autoimmune diseasesValeria Bruno, Giuseppe Battaglia, Ferdinando Nicoletti
Expert Opinion on Therapeutic Targets|August 14, 2024
The emerging role of Tetraspanin 32 in autoimmune diseases: from discovery to relevant theranostics?Paolo Fagone, Katia Mangano, Ferdinando Nicoletti
Current Opinion in Pharmacology|December 27, 2017
Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's diseaseFilippo Caraci, Ferdinando Nicoletti, Agata Copani
Pharmacological Reviews|December 30, 2008
Metabotropic glutamate 1 receptor: current concepts and perspectivesFrancesco Ferraguti, Luca Crepaldi, Ferdinando Nicoletti
Journal of Clinical Medicine|July 27, 2022
Relevance of Pathogenetic Mechanisms to Clinical Effectiveness of B-Cell-Depleting Monoclonal Antibodies in Multiple SclerosisLuca Massacesi, Alice Mariottini, Ferdinando Nicoletti
Neuropharmacology|June 5, 2012
Molecular mechanisms that desensitize metabotropic glutamate receptor signaling: an overviewLuisa Iacovelli, Ferdinando Nicoletti, Antonio De Blasi
Frontiers in Molecular Neuroscience|May 20, 2024
Editorial: Development and function of GABAergic interneurons in physiology and pathologiesMilena Cannella, Maria Vincenza Catania, Ferdinando Nicoletti
Autoimmunity Reviews|August 30, 2008
MIF in autoimmunity and novel therapeutic approachesStanislava Stosic-Grujicic, Ivana Stojanovic, Ferdinando Nicoletti
Pageof 58

Showing results (11-20 of 577) with videos related to

Sort By:
Pageof 58
Current Opinion in Pharmacology|May 13, 2018
Editorial overview: Neurosciences: Metabotropic glutamate receptors: still promising drug targets for CNS disordersFerdinando Nicoletti, Giuseppe Battaglia, Valria Bruno
Neuropharmacology|July 22, 2008
2008 Eruptions in metabotropic glutamate receptorsFerdinando Nicoletti, Graham Collingridge, Darryle Schoepp
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 21, 2010
The advent of monoclonal antibodies in the treatment of chronic autoimmune diseasesValeria Bruno, Giuseppe Battaglia, Ferdinando Nicoletti
Expert Opinion on Therapeutic Targets|August 14, 2024
The emerging role of Tetraspanin 32 in autoimmune diseases: from discovery to relevant theranostics?Paolo Fagone, Katia Mangano, Ferdinando Nicoletti
Current Opinion in Pharmacology|December 27, 2017
Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's diseaseFilippo Caraci, Ferdinando Nicoletti, Agata Copani
Pharmacological Reviews|December 30, 2008
Metabotropic glutamate 1 receptor: current concepts and perspectivesFrancesco Ferraguti, Luca Crepaldi, Ferdinando Nicoletti
Journal of Clinical Medicine|July 27, 2022
Relevance of Pathogenetic Mechanisms to Clinical Effectiveness of B-Cell-Depleting Monoclonal Antibodies in Multiple SclerosisLuca Massacesi, Alice Mariottini, Ferdinando Nicoletti
Neuropharmacology|June 5, 2012
Molecular mechanisms that desensitize metabotropic glutamate receptor signaling: an overviewLuisa Iacovelli, Ferdinando Nicoletti, Antonio De Blasi
Frontiers in Molecular Neuroscience|May 20, 2024
Editorial: Development and function of GABAergic interneurons in physiology and pathologiesMilena Cannella, Maria Vincenza Catania, Ferdinando Nicoletti
Autoimmunity Reviews|August 30, 2008
MIF in autoimmunity and novel therapeutic approachesStanislava Stosic-Grujicic, Ivana Stojanovic, Ferdinando Nicoletti
Pageof 58